Article Versions Notes

Yamauchi J, Tanabe K, Sato T, Nakagawa M, Matsuura E, Tsuboi Y, Tamaki K, Sakima H, Ishihara S, Ohta Y, et al. Efficacy of Corticosteroid Therapy for HTLV-1-Associated Myelopathy: A Randomized Controlled Trial (HAMLET-P). Viruses. 2022; 14(1):136. https://doi.org/10.3390/v14010136

Yamauchi, Junji, Kenichiro Tanabe, Tomoo Sato, Masanori Nakagawa, Eiji Matsuura, Yoshio Tsuboi, Keiko Tamaki, Hirokuni Sakima, Satoshi Ishihara, Yuki Ohta, and et al. 2022. "Efficacy of Corticosteroid Therapy for HTLV-1-Associated Myelopathy: A Randomized Controlled Trial (HAMLET-P)" Viruses 14, no. 1: 136. https://doi.org/10.3390/v14010136

Yamauchi, J., Tanabe, K., Sato, T., Nakagawa, M., Matsuura, E., Tsuboi, Y., Tamaki, K., Sakima, H., Ishihara, S., Ohta, Y., Matsumoto, N., Kono, K., Yagishita, N., Araya, N., Takahashi, K., Kunitomo, Y., Nagasaka, M., Coler-Reilly, A., Hasegawa, Y., ... Yamano, Y. (2022). Efficacy of Corticosteroid Therapy for HTLV-1-Associated Myelopathy: A Randomized Controlled Trial (HAMLET-P). Viruses, 14(1), 136. https://doi.org/10.3390/v14010136